{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:39:33Z","timestamp":1761057573463},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1984,1,1]],"date-time":"1984-01-01T00:00:00Z","timestamp":441763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[1984,1]]},"DOI":"10.1016\/0278-5846(84)90165-9","type":"journal-article","created":{"date-parts":[[2002,12,14]],"date-time":"2002-12-14T23:27:29Z","timestamp":1039908449000},"page":"277-283","source":"Crossref","is-referenced-by-count":15,"title":["Low dose bromocriptine: A study of acute effects in chronic medicated schizophrenics"],"prefix":"10.1016","volume":"8","author":[{"given":"Neal R.","family":"Cutler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip V.","family":"Jeste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farouk","family":"Karoum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst F.","family":"Schran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Jed","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0278-5846(84)90165-9_BIB1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/070674377101600603","article-title":"Drug treatment in schizophrenia","volume":"16","author":"Ban","year":"1971","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1016\/0278-5846(84)90165-9_BIB2","first-page":"153","article-title":"Disposition of dopaminergic ergot compounds following oral administration: Lisuride and Other Dopamine Agonists","author":"Burns","year":"1982"},{"key":"10.1016\/0278-5846(84)90165-9_BIB3_1","first-page":"645","article-title":"Sedative, hypnotic and antipsychotic effect of low dose apomorphine in man","volume":"16","author":"Corsini","year":"1977","journal-title":"Advances in Biochemical Psychophannacology"},{"key":"10.1016\/0278-5846(84)90165-9_BIB3_2","first-page":"1977","article-title":"Sedative, hypnotic and antipsychotic effect of low dose apomorphine in man","volume":"16","author":"Corsini","year":"1977","journal-title":"Advances in Biochemical Psychophannacology"},{"key":"10.1016\/0278-5846(84)90165-9_BIB4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0024-3205(82)90609-9","article-title":"Low-dose apomorphine reduces serum homovanillic acid concentrations in schizophrenic patients","volume":"30","author":"Cutler","year":"1982","journal-title":"Life Science"},{"key":"10.1016\/0278-5846(84)90165-9_BIB5","series-title":"Experimental Design in Psychological Research","author":"Edwards","year":"1972"},{"key":"10.1016\/0278-5846(84)90165-9_BIB6","first-page":"297","volume":"138","author":"Jeste","year":"1981","journal-title":"Changing Epidemiology of tardive dyskinesia: American Journal of Psychiatry"},{"key":"10.1016\/0278-5846(84)90165-9_BIB7","first-page":"1085","article-title":"Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disorders","volume":"18","author":"Jeste","year":"1983","journal-title":"Biological Psychiatry"},{"key":"10.1016\/0278-5846(84)90165-9_BIB8","first-page":"39","volume":"Vol. 1","author":"Karoum","year":"1982"},{"key":"10.1016\/0278-5846(84)90165-9_BIB9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.7350667","article-title":"Schizophrenia: elevated cerebrospinal fluid norepinephrine","volume":"207","author":"Lake","year":"1980","journal-title":"Science"},{"key":"10.1016\/0278-5846(84)90165-9_BIB10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00439271","article-title":"Effect of low-dose bromocriptine in treatment of psychosis: The dopann'ne autoreceptor-stimulation strategy","volume":"81","author":"Meltzer","year":"1983","journal-title":"Psychopharmacology"},{"key":"10.1016\/0278-5846(84)90165-9_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0024-3205(82)90394-0","article-title":"Pepti'des in the cerebrospinal fluid of neuropsychiatrie patients: An approach to central nervous system peptide function","volume":"31","author":"Post","year":"1982","journal-title":"Life Science"},{"key":"10.1016\/0278-5846(84)90165-9_BIB12","first-page":"429","article-title":"Dopamine autoreceptors: Pharmacology function and comparison post synaptic dopami ne receptors","volume":"3","author":"Roth","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/0278-5846(84)90165-9_BIB13","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/clinchem\/25.11.1928","article-title":"Specific analysis of ergot peptide alkaloids by radioimmunoassay","volume":"11","author":"Schran","year":"1979","journal-title":"Clinical Chemistry"},{"key":"10.1016\/0278-5846(84)90165-9_BIB14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.482929","article-title":"Dopamine auto \u2014 and post synaptic receptors: Electrophysiological evidence for differential sensitivity to dopamine agonists","volume":"206","author":"Skirboll","year":"1979","journal-title":"Science"},{"key":"10.1016\/0278-5846(84)90165-9_BIB15","series-title":"Research diagnostic criteria","author":"Spitzer","year":"1975"},{"key":"10.1016\/0278-5846(84)90165-9_BIB16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00428312","article-title":"Treatment of schizophrenia with ergot derivatives","volume":"66","author":"Tamminga","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/0278-5846(84)90165-9_BIB17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1126\/science.347574","article-title":"Schizophrenia symptoms improve with apomorphine","volume":"200","author":"Tamminga","year":"1978","journal-title":"Science"},{"key":"10.1016\/0278-5846(84)90165-9_BIB18","first-page":"661","article-title":"Pre and post synaptic action of bromocriptine: Its pharmacological effects in schizophrenia and neurological diseases","volume":"16","author":"Trabucchi","year":"1977","journal-title":"Advances in Biochemical Psychopharmacology"},{"key":"10.1016\/0278-5846(84)90165-9_BIB19","series-title":"American Psychiatric Association Annual Review","first-page":"112","article-title":"Biochemical and morphological aspects of schizophrenia","author":"Wyatt","year":"1982"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0278584684901659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0278584684901659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T20:50:06Z","timestamp":1583959806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0278584684901659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1984,1]]}},"alternative-id":["0278584684901659"],"URL":"https:\/\/doi.org\/10.1016\/0278-5846(84)90165-9","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[1984,1]]}}}